![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Active Filter(s):
Details:
Through the acquisition, Carlin expand its portfolio of OTC brands by including Penetrex, a unique formulation, using natural ingredients like Arnica, Vitamin B6 and Methylsulfonylmethane, used to treat joint and muscle pain.
Lead Product(s): Arnica Montana,Pyridoxine Hydrochloride,Dimethyl Sulfone
Therapeutic Area: Rheumatology Product Name: Penetrex
Highest Development Status: Approved Product Type: Large molecule
Partner/Sponsor/Collaborator: Carlin Consumer Health
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 30, 2024